ClinicalTrials.Veeva

Menu

PROPHYlactic Implantation of BIOlogic Mesh in Peritonitis (PROPHYBIOM)

A

A.O. Ospedale Papa Giovanni XXIII

Status and phase

Unknown
Phase 4

Conditions

Incisional Hernia

Treatments

Procedure: Direct suture of the anterior abdominal wall fascia
Device: Biological swine dermis not cross-linked prosthesis positioning in incisional hernia prevention

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

To evaluate the efficacy of the use of swine dermal collagen prosthesis implanted preperitoneally as a prophylactic procedure against incisional hernia in patients operated in urgency/emergency setting in contaminated/infected fields with peritonitis. The aim of the study is to reduce the incidence of incisional hernia from 50% to 20%.

Enrollment

90 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • • Patients aged > 18 years old

    • Clinical and/or laboratory and/or radiological evidence/signs of peritonitis of any origin (peritoneal reactivity, positive Blumberg sign, fever, free air/fluid in abdominal cavity, leucocytosis, increased CRP (C-reactive protein, lactic dehydrogenase (LDH), tachycardia, tachypnea, clinical or radiological evidence/suspect of bowel ischemia)
    • Eventual strong suspect of possible bacterial translocation (reduction of the natural intestinal barrier against bacterial translocation, i.e. bowel ischemia, bowel overdistension, intestinal occlusion, etc.)
    • Surgical indication for midline laparotomy independently from eventual previous laparotomies
    • Informed consent

Exclusion criteria

  • • Patients aged < 18 years old

    • Informed consent refusal
    • No Clinical and/or laboratory and/or radiological evidence/signs of peritonitis of any origin.
    • Surgical indication for laparotomies other than midline one
    • Pregnancy

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

90 participants in 2 patient groups

Treatment arm
Experimental group
Description:
Patients randomized to this arm will be operated for the primary disease and at the end of the intervention the laparotomy will be closed reinforcing the suture with a swine dermis biological prosthesis positioned sublay
Treatment:
Device: Biological swine dermis not cross-linked prosthesis positioning in incisional hernia prevention
Control arm
Active Comparator group
Description:
Patients randomized to this arm will be operated for the primary disease and at the end of the intervention the laparotomy will be closed by emi-continuous monofilament sutures with an intermediate-reabsorbable-time suture
Treatment:
Procedure: Direct suture of the anterior abdominal wall fascia

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems